Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02640079 · ClinicalTrials.gov registry record · NA
A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea
A NA study of Pain Catastrophizing and Primary Dysmenorrhea, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT02640079 is a NA study of Pain Catastrophizing and Primary Dysmenorrhea that has completed, run by University of California, Los Angeles. The registered enrollment target is 24 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02640079, a NA study of Pain Catastrophizing and Primary Dysmenorrhea, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to test the feasibility and efficacy of a brief group therapy treatment program focused on reducing pain catastrophizing in adolescents and young adults (ages 16-25) with menstrual pain.
Conditions Studied
Interventions
- BEHAVIORAL Cognitive behavioral therapy
Study Locations (1)
California
- University of California, Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-01 |
| Est. Completion | 2017-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02640079
The ClinicalTrials.gov registry entry for NCT02640079 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pain Catastrophizing appearing as the primary indexed condition, and to 1 intervention - of which Cognitive behavioral therapy is the first listed.
NCT02640079 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02640079 about?
NCT02640079 is a clinical study titled "A Behavioral Intervention for Pain Catastrophizing in Primary Dysmenorrhea". The purpose of this study is to test the feasibility and efficacy of a brief group therapy treatment program focused on reducing pain catastrophizing in adolescents and young adults (ages 16-25) with menstrual pain.
What is the current status of trial NCT02640079?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2016-01. Estimated completion is 2017-11.
What conditions does trial NCT02640079 study?
This clinical trial studies the following conditions: Pain Catastrophizing, Primary Dysmenorrhea.
What interventions are being tested in trial NCT02640079?
The interventions under investigation include: Cognitive behavioral therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02640079?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02640079 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain Catastrophizing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.